NDLR 2021 has been postponed until March 2022
Exact dates will be announced once confirmed. Join the mailing list at the button below to keep up to date with the latest announcements.
All current registrations will be rolled over to the 2022 Meeting. Those who have already registered and plan to attend the 2022 Meeting do not need to do anything to secure their attendance. Should you wish to cancel your registration and have your fee refunded, please let us know here.
If you booked your accommodation through Arinex as part of your booking process, you will receive a full refund for any amounts paid to date. These refunds will be processed within the next 30 days, and we appreciate your patience while we work through this process.
The Scientific and Organising Committees invite you to participate in the 8th New Directions in Leukaemia Research (NDLR) meeting to be held at the Brisbane Convention and Exhibition Centre in Queensland, Australia, in March, 2022.
The goal of the NDLR conferences is to bring together scientists and clinicians to discuss emerging paradigms and breakthroughs at the forefront of leukaemia research and treatment, from the molecular basis of leukaemia to new therapies emerging in the clinic.
As one of the premier international leukaemia conferences, NDLR 2022 will again bring together early-career investigators and senior scientists. Attendees will hear of recent findings in basic and translational research through interaction with local and international experts, allowing new collaborations to be forged.
Leukaemia research has undergone an unprecedented revolution in recent years and this is beginning to deliver a real and significant impact in the clinic. The biennial NDLR conferences offer a unique opportunity for scientists and clinicians to keep pace with such a rapidly evolving field.
We look forward to seeing you at NDLR 2022.
Associate Professors Matthew McCormack & Ross Dickins (co-chairs)
NDLR 2018 Delegates